November 25, 2021

Elias Theodorou Knocking Out Cannabis as a Prohibited Substance in Sport

Midas Letter
Midas Letter
Elias Theodorou Knocking Out Cannabis as a Prohibited Substance in Sport
/

Former UFC middleweight fighter Elias Theodorou will return to the octagon on December 18th. But, he will not only be fighting another athlete; he is also making history as he knocks out cannabis from the prohibited substance list in sport in the U.S.

“The Spartan” is set to face Bryan Baker in the main event of Colorado Combat Club 10. And in a historic first, the Ultimate Fighter winner will become the first professional athlete to compete in the U.S. with a therapeutic use exemption (TUE) for medical cannabis.

“[I] went to British Columbia, where I applied for a therapeutic use exemption and was approved for one. I was able to validate it this past year when I won against another formidable opponent for a promotion called Rise, fighting the stigma where I validated my therapeutic use exemption, set a precedent not only for myself but also taking that precedent to a different commission now in Colorado. So I am both the first sanctioned cannabis athlete in Canada and now the U.S. and looking to validate it again Dec 18 to make history not only for myself but all other athletes.” – Elias Theodorou

In addition to fighting, Theodorou is co-promoting the event while launching¬†an exclusive NFT collection. The NFT collection will commemorate¬†his #FIGHTtheSTIMGA victory, which has successfully challenged professional athletes’ penalization of cannabis use.

Watch the full interview to learn how Elias uses cannabis in a lead-up to a fight, the cannabis culture in BJJ/MMA, and his historic fight on December 18.

Related Articles

Disclosure

Midas Letter is provided as a source of information only, and is in no way to be construed as investment advice. James West, the author and publisher of the Midas Letter, is not authorized to provide investor advice, and provides this information only to readers who are interested in knowing what he is investing in and how he reaches such decisions.

Investing in emerging public companies involves a high degree of risk and investors in such companies could lose all their money. Always consult a duly accredited investment professional in your jurisdiction prior to making any investment decision.

Midas Letter occasionally accepts fees for advertising and sponsorship from public companies featured on this site. James West and/or Midas Letter may also receive compensation from companies affiliated with companies featured on this site. James West and/or Midas Letter also invests in companies on this site and so readers should view all information on this site as biased.